Susquehanna International Group’s Cidara Therapeutics CDTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.67M | Sell |
54,840
-287,636
| -84% | -$14M | ﹤0.01% | 1958 |
|
|
2025
Q1 | $7.38M | Buy |
342,476
+299,853
| +704% | +$6.46M | ﹤0.01% | 834 |
|
|
2024
Q4 | $1.15M | Buy |
+42,623
| New | +$1.15M | ﹤0.01% | 2797 |
|
|
2024
Q1 | – | Sell |
-644
| Closed | -$10.2K | – | 5664 |
|
|
2023
Q4 | $10.2K | Buy |
+644
| New | +$10.2K | ﹤0.01% | 5735 |
|
|
2023
Q3 | – | Sell |
-1,213
| Closed | -$27.4K | – | 5633 |
|
|
2023
Q2 | $27.4K | Sell |
1,213
-4,012
| -77% | -$90.6K | ﹤0.01% | 5317 |
|
|
2023
Q1 | $133K | Buy |
+5,225
| New | +$133K | ﹤0.01% | 5109 |
|
|
2022
Q1 | – | Sell |
-1,112
| Closed | -$28K | – | 5799 |
|
|
2021
Q4 | $28K | Buy |
+1,112
| New | +$28K | ﹤0.01% | 5578 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 5392 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 5372 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 4800 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 4463 |
|
|
2020
Q2 | – | Sell |
-2,177
| Closed | -$108K | – | 4307 |
|
|
2020
Q1 | $108K | Buy |
2,177
+1,674
| +333% | +$83K | ﹤0.01% | 4028 |
|
|
2019
Q4 | $39K | Sell |
503
-135
| -21% | -$10.5K | ﹤0.01% | 3810 |
|
|
2019
Q3 | $25K | Buy |
+638
| New | +$25K | ﹤0.01% | 4271 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 3779 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 3487 |
|
|
2018
Q2 | – | Hold |
0
| – | – | – | 3744 |
|
|
2018
Q1 | – | Hold |
0
| – | – | – | 3484 |
|
|
2017
Q3 | – | Sell |
-2,331
| Closed | -$350K | – | 3264 |
|
|
2017
Q2 | $350K | Buy |
+2,331
| New | +$350K | ﹤0.01% | 2648 |
|
|
2017
Q1 | – | Sell |
-1,011
| Closed | -$210K | – | 3375 |
|
|
2016
Q4 | $210K | Buy |
+1,011
| New | +$210K | ﹤0.01% | 3689 |
|
|
2016
Q3 | – | Sell |
-503
| Closed | -$104K | – | 3062 |
|
|
2016
Q2 | $104K | Buy |
+503
| New | +$104K | ﹤0.01% | 2906 |
|